Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | hypothetical protein | 0.0084 | 0.0557 | 0.0487 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0327 | 0.2978 | 0.3769 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.004 | 0.0122 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0394 | 0.3636 | 0.4624 |
Brugia malayi | MH2 domain containing protein | 0.0049 | 0.0218 | 0.0145 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0122 | 0.1209 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0066 | 0.0387 | 0.0316 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0066 | 0.0387 | 0.3825 |
Loa Loa (eye worm) | hypothetical protein | 0.0707 | 0.675 | 0.6726 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0811 | 0.7779 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0129 | 0.1013 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.0304 | 0.0299 |
Schistosoma mansoni | hypothetical protein | 0.0707 | 0.675 | 0.8665 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.004 | 0.0122 | 0.0049 |
Echinococcus multilocularis | TGF beta signal transducer SmadC | 0.0049 | 0.0218 | 0.0187 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0122 | 0.1209 |
Echinococcus granulosus | Ataxin 2 N terminaldomain containing protein | 0.0058 | 0.0304 | 0.0299 |
Leishmania major | DNA polymerase kappa, putative | 0.004 | 0.0122 | 0.0078 |
Brugia malayi | RNA binding protein | 0.0394 | 0.3636 | 0.3589 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0129 | 0.1013 | 0.5 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.004 | 0.0122 | 1 |
Echinococcus multilocularis | Ataxin 2, N terminal,domain containing protein | 0.0058 | 0.0304 | 0.0299 |
Brugia malayi | MH2 domain containing protein | 0.0049 | 0.0218 | 0.0145 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0394 | 0.3636 | 0.3589 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0122 | 0.1209 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0811 | 0.7779 | 0.7762 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.004 | 0.0122 | 0.1209 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0327 | 0.2978 | 0.2926 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0122 | 0.1209 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0798 | 0.7645 | 0.9826 |
Loa Loa (eye worm) | Smad1 | 0.0049 | 0.0218 | 0.0145 |
Brugia malayi | N-terminal motif family protein | 0.0177 | 0.1486 | 0.1423 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0129 | 0.1013 | 0.5 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0049 | 0.0218 | 0.0145 |
Trypanosoma brucei | unspecified product | 0.004 | 0.0122 | 0.1209 |
Brugia malayi | MH2 domain containing protein | 0.0724 | 0.6915 | 0.6892 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0811 | 0.7779 | 1 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0327 | 0.2978 | 0.2926 |
Brugia malayi | Smad1 | 0.0049 | 0.0218 | 0.0145 |
Schistosoma mansoni | hypothetical protein | 0.0503 | 0.4724 | 0.6035 |
Mycobacterium ulcerans | DNA polymerase IV | 0.004 | 0.0122 | 0.5 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0129 | 0.1013 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0035 | 0.0076 | 0.0002 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.004 | 0.0122 | 0.1209 |
Loa Loa (eye worm) | hypothetical protein | 0.1035 | 1 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.004 | 0.0122 | 0.1209 |
Brugia malayi | MH1 domain containing protein | 0.0049 | 0.0218 | 0.0145 |
Schistosoma mansoni | Smad4 | 0.0049 | 0.0218 | 0.0187 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.004 | 0.0122 | 0.0078 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.1035 | 1 | 1 |
Onchocerca volvulus | 0.0147 | 0.1188 | 0.7891 | |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0035 | 0.0076 | 0.0002 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0122 | 0.1209 |
Echinococcus multilocularis | geminin | 0.0503 | 0.4724 | 0.6035 |
Brugia malayi | hypothetical protein | 0.0035 | 0.0076 | 0.0002 |
Echinococcus multilocularis | mothers against decapentaplegic 5 | 0.0049 | 0.0218 | 0.0187 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.1035 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0129 | 0.1013 | 0.0946 |
Schistosoma mansoni | smad1 5 8 and | 0.0049 | 0.0218 | 0.0187 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.004 | 0.0122 | 0.0078 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.0049 | 0.0218 | 0.0187 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0076 | 0.0382 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.004 | 0.0122 | 0.5 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.004 | 0.0122 | 0.0063 |
Schistosoma mansoni | hypothetical protein | 0.0503 | 0.4724 | 0.6035 |
Brugia malayi | hypothetical protein | 0.0147 | 0.1188 | 0.1123 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0394 | 0.3636 | 0.3589 |
Schistosoma mansoni | tar DNA-binding protein | 0.0394 | 0.3636 | 0.4624 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0811 | 0.7779 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.004 | 0.0122 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0327 | 0.2978 | 0.3769 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0129 | 0.1013 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0129 | 0.1013 | 1 |
Echinococcus granulosus | TGF beta signal transducer SmadC | 0.0049 | 0.0218 | 0.0187 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.004 | 0.0122 | 0.0049 |
Echinococcus multilocularis | tar DNA binding protein | 0.0394 | 0.3636 | 0.4624 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0811 | 0.7779 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.0387 | 0.0316 |
Echinococcus granulosus | GPCR family 2 | 0.0327 | 0.2978 | 0.3769 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0327 | 0.2978 | 0.3769 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0811 | 0.7779 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0811 | 0.7779 | 0.7762 |
Leishmania major | DNA polymerase eta, putative | 0.0066 | 0.0387 | 0.3031 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0066 | 0.0387 | 0.3031 |
Echinococcus multilocularis | dna polymerase eta | 0.0066 | 0.0387 | 0.0407 |
Loa Loa (eye worm) | TAR-binding protein | 0.0394 | 0.3636 | 0.3589 |
Echinococcus granulosus | geminin | 0.0503 | 0.4724 | 0.6035 |
Giardia lamblia | DINP protein human, muc B family | 0.004 | 0.0122 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0327 | 0.2978 | 0.3769 |
Schistosoma mansoni | DNA polymerase eta | 0.0066 | 0.0387 | 0.0407 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0076 | 0.0382 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0122 | 0.1209 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0327 | 0.2978 | 0.3769 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0724 | 0.6915 | 0.6892 |
Schistosoma mansoni | smad | 0.0049 | 0.0218 | 0.0187 |
Schistosoma mansoni | tar DNA-binding protein | 0.0394 | 0.3636 | 0.4624 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.004 | 0.0122 | 0.0078 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.004 | 0.0122 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0129 | 0.1013 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0049 | 0.0218 | 0.0145 |
Echinococcus multilocularis | smad | 0.0049 | 0.0218 | 0.0187 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0327 | 0.2978 | 0.3769 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0327 | 0.2978 | 0.2926 |
Echinococcus granulosus | dna polymerase kappa | 0.004 | 0.0122 | 0.0063 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.004 | 0.0122 | 0.0078 |
Onchocerca volvulus | Rap guanine nucleotide exchange factor 1 homolog | 0.0177 | 0.1486 | 1 |
Echinococcus granulosus | Smad4 | 0.0049 | 0.0218 | 0.0187 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0129 | 0.1013 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0122 | 0.1209 |
Loa Loa (eye worm) | RNA binding protein | 0.0394 | 0.3636 | 0.3589 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.004 | 0.0122 | 0.0063 |
Echinococcus multilocularis | dna polymerase kappa | 0.004 | 0.0122 | 0.0063 |
Brugia malayi | MH1 domain containing protein | 0.0049 | 0.0218 | 0.0145 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0076 | 0.0382 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0122 | 0.1209 |
Echinococcus multilocularis | GPCR, family 2 | 0.0327 | 0.2978 | 0.3769 |
Schistosoma mansoni | smad1 5 8 and | 0.0049 | 0.0218 | 0.0187 |
Schistosoma mansoni | hypothetical protein | 0.0327 | 0.2978 | 0.3769 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0122 | 0.1209 |
Loa Loa (eye worm) | hypothetical protein | 0.0327 | 0.2978 | 0.2926 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0076 | 0.0382 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0811 | 0.7779 | 1 |
Echinococcus granulosus | mothers against decapentaplegic 5 | 0.0049 | 0.0218 | 0.0187 |
Loa Loa (eye worm) | hypothetical protein | 0.0177 | 0.1486 | 0.1423 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0811 | 0.7779 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0327 | 0.2978 | 0.3769 |
Schistosoma mansoni | smad1 5 8 and | 0.0049 | 0.0218 | 0.0187 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.004 | 0.0122 | 0.0063 |
Schistosoma mansoni | tar DNA-binding protein | 0.0394 | 0.3636 | 0.4624 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.004 | 0.0122 | 0.0078 |
Echinococcus granulosus | dna polymerase eta | 0.0066 | 0.0387 | 0.0407 |
Schistosoma mansoni | tar DNA-binding protein | 0.0394 | 0.3636 | 0.4624 |
Loa Loa (eye worm) | hypothetical protein | 0.0129 | 0.1013 | 0.0946 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.004 | 0.0122 | 0.0063 |
Brugia malayi | TAR-binding protein | 0.0394 | 0.3636 | 0.3589 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0035 | 0.0076 | 0.0002 |
Echinococcus multilocularis | Smad4 | 0.0049 | 0.0218 | 0.0187 |
Loa Loa (eye worm) | hypothetical protein | 0.0147 | 0.1188 | 0.1123 |
Echinococcus granulosus | smad | 0.0049 | 0.0218 | 0.0187 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0707 | 0.675 | 0.6726 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.004 | 0.0122 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0724 | 0.6915 | 0.6892 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0122 | 0.1209 |
Schistosoma mansoni | tar DNA-binding protein | 0.0394 | 0.3636 | 0.4624 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0076 | 0.0002 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | = 26.8 uM | Tested for cytotoxicity against human cancer cell lines HL-60(TB) (leukemia) cell line. | ChEMBL. | 8410995 |
GI50 (functional) | = 26.8 uM | Tested for cytotoxicity against human cancer cell lines HL-60(TB) (leukemia) cell line. | ChEMBL. | 8410995 |
GI50 (functional) | = 28.6 uM | Tested for cytotoxicity against COLO 205 (colon cancer) cell line. | ChEMBL. | 8410995 |
GI50 (functional) | = 28.6 uM | Tested for cytotoxicity against COLO 205 (colon cancer) cell line. | ChEMBL. | 8410995 |
GI50 (functional) | = 33 uM | Tested for cytotoxicity against DMS 273 (small-cell lung cancer) cell line. | ChEMBL. | 8410995 |
GI50 (functional) | = 33 uM | Tested for cytotoxicity against DMS 273 (small-cell lung cancer) cell line. | ChEMBL. | 8410995 |
GI50 (functional) | = 52.7 uM | In vitro cytotoxicity against SF-295 (CNS cancer) cell line. | ChEMBL. | 8410995 |
GI50 (functional) | = 52.7 uM | In vitro cytotoxicity against SF-295 (CNS cancer) cell line. | ChEMBL. | 8410995 |
GI50 (functional) | = 83.8 uM | Tested for cytotoxicity against M14 melanoma | ChEMBL. | 8410995 |
GI50 (functional) | = 83.8 uM | Tested for cytotoxicity against M14 melanoma | ChEMBL. | 8410995 |
GI50 (functional) | > 100 uM | Tested for cytotoxicity against NCI-H522 (non-small-cell lung cancer) cell line. | ChEMBL. | 8410995 |
GI50 (functional) | > 100 uM | Tested for cytotoxicity against OVCAR-3 (ovarian cancer) cell line. | ChEMBL. | 8410995 |
GI50 (functional) | > 100 uM | Tested for cytotoxicity against CAKI-1 renal cancer | ChEMBL. | 8410995 |
GI50 (functional) | > 100 uM | Tested for cytotoxicity against NCI-H522 (non-small-cell lung cancer) cell line. | ChEMBL. | 8410995 |
GI50 (functional) | > 100 uM | Tested for cytotoxicity against OVCAR-3 (ovarian cancer) cell line. | ChEMBL. | 8410995 |
GI50 (functional) | > 100 uM | Tested for cytotoxicity against CAKI-1 renal cancer | ChEMBL. | 8410995 |
IC50 (functional) | > 40 uM | In vitro inhibition of bovine electrophoretically homogeneous tubulin polymerization. | ChEMBL. | 8410995 |
IC50 (functional) | > 40 uM | In vitro inhibition of bovine electrophoretically homogeneous tubulin polymerization. | ChEMBL. | 8410995 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.